logo
Sign in

ANIK Stock Price, Chart, Stats & News

Anika Therapeutics, Inc.
Save
191.87M
Market cap
Current P/E
34.60x
Forward P/E

ANIK chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
56.56%
Operating margin
-9.80%
Pretax margin
-8.25%
Net margin
-9.64%
Effective tax rate
-7.22%
ROA
-5.72%
ROE
-7.42%
D/E
0.17x
Interest coverage ratio
-93.65x

ANIK valuation

P/E
P/S
1.83x
P/B
1.42x
P/CF
18.22x
P/FCF
47.21x
P/OCF
18.22x
PEG
-0.28x
EV multiple
-58.50x

About

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform.

Similar securities

Based on sector and market capitalization

Report issue